Evodiamine

General

Type : Derivative of Evodiamine,Natural,beta-carboline,Not A\/B H target,Multitarget

Chemical_Nomenclature : (1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

Canonical SMILES : CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3

InChI : InChI=1S\/C19H17N3O\/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22\/h2-9,18,20H,10-11H2,1H3\/t18-\/m0\/s1

InChIKey : TXDUTHBFYKGSAH-SFHVURJKSA-N

Other name(s) : d-Evodiamine,(+)-Evodiamine,UNII-C01825BVNL,CHEBI:4948,CHEMBL463165,DTXSID10966123,ZINC898159


MW : 303.4

Formula : C19H17N3O

CAS_number : 518-17-2

PubChem : 442088

UniChem : TXDUTHBFYKGSAH-SFHVURJKSA-N

IUPHAR :

Wikipedia :

Target

Families : Evodiamine ligand of proteins in family: BCHE

Stucture :

Protein :

References (6)

Title : Protective effects of evodiamine in experimental paradigm of Alzheimer's disease - Wang_2018_Cogn.Neurodyn_12_303
Author(s) : Wang D , Wang C , Liu L , Li S
Ref : Cogn Neurodyn , 12 :303 , 2018
Abstract : Wang_2018_Cogn.Neurodyn_12_303
ESTHER : Wang_2018_Cogn.Neurodyn_12_303
PubMedSearch : Wang_2018_Cogn.Neurodyn_12_303
PubMedID: 29765479

Title : Pharmacological Basis for the Use of Evodiamine in Alzheimer's Disease: Antioxidation and Antiapoptosis - Zhang_2018_Int.J.Mol.Sci_19_
Author(s) : Zhang Y , Wang J , Wang C , Li Z , Liu X , Zhang J , Lu J , Wang D
Ref : Int J Mol Sci , 19 : , 2018
Abstract : Zhang_2018_Int.J.Mol.Sci_19_
ESTHER : Zhang_2018_Int.J.Mol.Sci_19_
PubMedSearch : Zhang_2018_Int.J.Mol.Sci_19_
PubMedID: 29883380

Title : Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine - Huang_2014_Eur.J.Med.Chem_81C_15
Author(s) : Huang G , Kling B , Darras FH , Heilmann J , Decker M
Ref : Eur Journal of Medicinal Chemistry , 81C :15 , 2014
Abstract : Huang_2014_Eur.J.Med.Chem_81C_15
ESTHER : Huang_2014_Eur.J.Med.Chem_81C_15
PubMedSearch : Huang_2014_Eur.J.Med.Chem_81C_15
PubMedID: 24819955

Title : Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine - Decker_2005_Eur.J.Med.Chem_40_305
Author(s) : Decker M
Ref : Eur Journal of Medicinal Chemistry , 40 :305 , 2005
Abstract : Decker_2005_Eur.J.Med.Chem_40_305
ESTHER : Decker_2005_Eur.J.Med.Chem_40_305
PubMedSearch : Decker_2005_Eur.J.Med.Chem_40_305
PubMedID: 15725500

Title : Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice - Wang_2001_Eur.J.Pharmacol_413_221
Author(s) : Wang HH , Chou CJ , Liao JF , Chen CF
Ref : European Journal of Pharmacology , 413 :221 , 2001
Abstract : Wang_2001_Eur.J.Pharmacol_413_221
ESTHER : Wang_2001_Eur.J.Pharmacol_413_221
PubMedSearch : Wang_2001_Eur.J.Pharmacol_413_221
PubMedID: 11226396

Title : Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa - Park_1996_Planta.Med_62_405
Author(s) : Park CH , Kim SH , Choi W , Lee YJ , Kim JS , Kang SS , Suh YH
Ref : Planta Med , 62 :405 , 1996
Abstract : Park_1996_Planta.Med_62_405
ESTHER : Park_1996_Planta.Med_62_405
PubMedSearch : Park_1996_Planta.Med_62_405
PubMedID: 8923803